|
|
Volumn 361, Issue 13, 2009, Pages 1301-1303
|
|
An old AML drug revisited
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTARABINE;
DAUNORUBICIN;
IDARUBICIN;
ACUTE GRANULOCYTIC LEUKEMIA;
ADD ON THERAPY;
ALLOGENEIC STEM CELL TRANSPLANTATION;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CLINICAL TRIAL;
CYTOGENETICS;
EDITORIAL;
HUMAN;
MOLECULAR GENETICS;
MYELODYSPLASTIC SYNDROME;
ONCOLOGY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROMYELOCYTIC LEUKEMIA;
AGE FACTORS;
ANTIBIOTICS, ANTINEOPLASTIC;
DAUNORUBICIN;
HUMANS;
LEUKEMIA, MYELOMONOCYTIC, ACUTE;
MUTATION;
REMISSION INDUCTION;
SURVIVAL RATE;
|
|
EID: 70349448379
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe0905678 Document Type: Editorial |
|
Times cited : (5)
|
|
References (5)
|
